KYMOS Market Share Analysis for May 2026

CRO for Bioanalysis of small molecules & generics. Preclinical, clinical I-IV and bioequivalence studies. GLP & GCP compliant.

Sports > Sports - Other

Domainkymos.com

Year Founded2001

Employees51 - 200

Annual Revenue$15M - $25M

KYMOS

KYMOS (including company regionals)

kymos.com

See more website traffic and engagement information

KYMOS Revenue up to May 2026 is 15M - 25M

revenue generated by KYMOS top domains

KYMOS top domains revenue over 3 years

Revenue for KYMOS top domains

kymos.com15M - 25M

See more with Sales Intelligence

Total visits to KYMOS's top domains

Understand KYMOS market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

kymos.com15.1K

See more with Sales Intelligence

Avg. visit duration in KYMOS's top domains

Analyze KYMOS engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

kymos.com00:00:40

See more with Sales Intelligence

Avg. pageviews on KYMOS's top domains

See how KYMOS keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

kymos.com2.53

See more with Sales Intelligence

KYMOS top competitors by domain

Top similar sites in May 2026, ranked by their affinity

coriolis-pharma.comCompany NameCoriolis PharmaEmployees51 - 200HQGermany, MontabaurAnnual revenue$15M - $25MTotal visits8.4KScience and Education > Chemistry

Top technologies used by KYMOS

These are the website technologies, by industry, used by KYMOS top domains

Widget (8)

reCAPTCHA

Advertising (4)

DoubleClick

Content Management System (4)

WordPress

Conversion & Analytics (3)

Google Analytics

More Technologies

10

See all

News & Signals from KYMOS

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsKymos Group acquires Particle Analytical ApS.Kymos Group acquired Particle Analytical to strengthen its European expansion and Grifols acquired Canadian Plasma Resources to continue with its diversification strategy.

NewsSyvento integrates with Kymos Group.By combining SyVento's expertise in preclinical/clinical drug development, liposomal/LNP technologies and GMP manufacturing of clinical/ commercial batches with Kymos' excellence in advanced bioanalytical and CMC services under GCP, GLP, GxP, and GMP standards for mRNA, oligonucleotides, lipids, and LNPs, this collaboration will deliver comprehensive solutions for RNA-based therapeutics.

NewsKymos Group launched Kinetic turbidimetric and Recombinant Cascade Reagent on Mar 10th '25.To provide its clients with maximum flexibility, Kymos Group has recently added the Kinetic turbidimetric and Recombinant Cascade Reagent (rCR) methods and now its portfolio is fully comprehensive.